IN-VITRO CYTOLYTIC ACTIVITY OF LYMPHOCYTES FROM TUMOR-DRAINING LYMPH-NODES IS ASSOCIATED WITH INCREASED NUMBERS OF CD8+ CELLS AND INCREASEDCYTOKINE PRODUCTION
D. Holley et al., IN-VITRO CYTOLYTIC ACTIVITY OF LYMPHOCYTES FROM TUMOR-DRAINING LYMPH-NODES IS ASSOCIATED WITH INCREASED NUMBERS OF CD8+ CELLS AND INCREASEDCYTOKINE PRODUCTION, The Journal of surgical research, 58(1), 1995, pp. 33-37
A murine footpad tumor model was used to determine the cytotoxic activ
ity, tumor specificity, phenotypic profile, and cytokine production of
stimulated cells from draining lymph nodes (DLN). Popliteal DLN from
5-day-old P-815 footpad tumors were stimulated with 10(-7) M phorbol 1
2, 13-dibutyrate + 5 X 10(-7) M ionomycin for 16 hr and cultured in IL
-2 (20 units/ml) for 7 or 14 days without autologous tumor. Most cells
in both groups were CD3(+) (93% at Day 7, 99% at Day 14); however, th
e percentage of CD8(+) cells increased as the cell population matured
in the presence of low-dose IL-2. On Day 7, the phenotypic profile was
62% CD4(+) and 29% CD8(+), whereas on Day 14 it was 16% CD4(+) and 81
% CD8(+). Similarly, in vitro cytokine production increased with time
in culture. After 7 days, the Bevel of tumor necrosis factor-alpha (TN
F-alpha) was 220 pg/mL and the interferon-gamma (IF-gamma) production
was 150 pg/ml. At Day 14 the TNF level had increased to 500 pg/ml, and
IF production had increased to 350 pg/ml. These increases in the CD8(
+) population and in cytokine production correlated with the increase
in the percentage of target cells killed by the DLN cells. Cytolytic a
ctivity against P-815 was only 13% on Day 7 but 39% on Day 14. Neither
group of effector cells (Day 7 or Day 14) had any cytolytic activity
against the syngeneic tumor cell line L-1210, demonstrating the tumor
specificity of the DLN cells. We describe a model for generating tumor
-specific cytotoxic T-cells that have significant cytokine production,
which may account for previously described in vivo activity. (C) 1995
Academic Press, Inc.